The Valley Desk

NCT05938725 · Interventional trial

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Lupus Nephritis, Lupus Nephritis - WHO Class IV, Lupus Nephritis - World Health Organization (WHO) Class III

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov